What You Should Know: – Today, Komodo Health announces the acquisition of Breakaway Partners to improve patient access to effective… Continue Reading
Articles
PulmoSIM Therapeutics Announces Strategic Partnership with Top Respiratory Hospitals to Initiate Clinical Development of PT001 to Treat Pulmonary Arterial Hypertension
PulmoSIM Therapeutics (PulmoSIM), the pharmaceutical subsidiary of VeriSIM Life, Inc., is pleased to announce today that it has entered into… Continue Reading
Collective Health’s Partnership Program Launches with Inclusion of Livongo, Hinge Health
Amid the growing digital health ecosystem, Collective Health is making it easier for employers to manage their various offerings through… Continue Reading
ImaginAB Announces Extension of Long-Standing Partnership with Boehringer Ingelheim
ImaginAb Inc, a market-leading global biotechnology company, focused on developing next-generation immuno oncology imaging agents and therapeutic radiopharmaceuticals (RPT), today… Continue Reading
Welocalize Celebrates Its 19th Acquisition as Next Level Globalization Joins
Welocalize, ranked as one of the world’s largest LSPs by language industry intelligence firms CSA Research, Nimdzi, and Slator, announces… Continue Reading
EV Biologics Signs LOI with Lonza Cell & Gene Therapy
EV Biologics Corp., (OTC PINK: YECO) today announced that it has signed a Letter of Intent (LOI) with Lonza Cell… Continue Reading
ImmPACT Bio Announces Completion of Merger with Kalthera to Progress Next-Generation CAR T Therapies for the Treatment of Cancer
ImmPACT Bio USA, Inc., a company developing novel cell therapies for treating cancer, today announced its merger with Kalthera, Inc.,… Continue Reading
Brooklyn ImmunoTherapeutics Completes Acquisition of Novellus Therapeutics
Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine and gene editing/cell… Continue Reading
9 Meters Biopharma, Inc. Announces the Acquisition of Humanized Anti-GIP Monoclonal Antibody from Lobesity
9 Meters Biopharma, Inc. (NASDAQ: NMTR), a clinical-stage company focused on rare and unmet needs in gastroenterology, today announced that… Continue Reading
Cybersecurity: The Hidden Health Tech Crisis No One’s Talking About
The life-saving capabilities of technology in a healthcare environment are beyond dispute. Medical professionals in hospital environments rely on networked… Continue Reading